PDZD2
PDZD2 (PDZ domain containing 2, also known as PDZK3 and KIAA0300) is a large multi-domain protein that contains six PDZ domains. It shares sequence similarity with pro-interleukin-16 and is linked to the early stages of prostate tumorigenesis. Browse Assay Genie's current range of PDZD2 research reagents below, or read on for the biology behind the target.
PDZD2 is a multi-domain protein defined by six PDZ domains, modular regions that are the hallmark of the PDZ domain containing gene group. Its sequence is similar to that of pro-interleukin-16 (pro-IL-16), and it appears to share features of that precursor's biology. Like pro-IL-16, the encoded protein localizes to the endoplasmic reticulum, and it is thought to be cleaved by a caspase. Cleavage is proposed to release a secreted peptide that contains two PDZ domains.
UniProt lists the subcellular locations of PDZD2 as the nucleus, cytoplasm, endoplasmic reticulum and secreted fraction, which fits a protein that exists both as a cellular form and as a processed, released fragment. The PDZD2 gene encodes a very large polypeptide, and researchers studying this PDZD2 protein often need to distinguish the full-length form from its cleavage products.
The gene has been known by several names. HGNC records the approved name as PDZ domain containing 2, with the previous name PDZ domain containing 3 and the aliases PDZK3 and KIAA0300. In terms of disease relevance, the NCBI Gene summary reports that the gene is upregulated in primary prostate tumours and may be involved in the early stages of prostate tumorigenesis. That observation makes PDZD2 a point of interest in prostate cancer research. Beyond this, the summary does not describe a defined enzymatic function or signalling pathway, so the molecular role of PDZD2 remains an open question for experimental work.
PDZD2 is upregulated in primary prostate tumours and may contribute to the early stages of prostate tumorigenesis.
With six PDZ domains, PDZD2 is a useful subject for studying how PDZ modules shape large multi-domain proteins.
PDZD2 is thought to be cleaved by a caspase to release a secreted peptide containing two PDZ domains.
PDZD2 localizes to the endoplasmic reticulum, like pro-IL-16, and is also reported in the nucleus, cytoplasm and secreted fraction.
The source data do not define a specific molecular function. PDZD2 contains six PDZ domains, resembles pro-IL-16, localizes to the endoplasmic reticulum and is thought to be caspase-cleaved to give a secreted two-PDZ-domain peptide. It is upregulated in primary prostate tumours.
HGNC lists PDZD2 as PDZ domain containing 2. Previous symbols and aliases include PDZK3 and KIAA0300, and the previous name was PDZ domain containing 3. UniProt calls the protein PDZ domain-containing protein 2 (accession O15018).
A rat ortholog, Pdzd2, is recorded in the data supplied. On disease, the NCBI Gene summary notes upregulation in primary prostate tumours and a possible role in early prostate tumorigenesis. Check the datasheet of any product for its validated reactivity.
Other PDZ domain containing proteins and targets related to pro-IL-16 biology and caspase processing.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O15018; product specifications from Assay Genie datasheets.